Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 166–180 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5303 C3 Deficiency Genetic Test This test identifies inherited mutations in the C3 gene, which are responsible for complement C3 deficiency, a primary immunodeficiency.	Blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C3 gene", "Complement C3 deficiency"] Parameters [] Preparation [] Indications ["Symptomatic patients suspected of C3 deficiency", "At-risk family members of individuals with C3 deficiency", "Pre-conception carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21643-9 ICD-10: D84.1 Clinical summary This test identifies inherited mutations in the C3 gene, which are responsible for complement C3 deficiency, a primary immunodeficiency.
TEST-5343 C5 Gene (Complement C5) Deficiency Genetic Test This test identifies pathogenic variants in the C5 gene associated with complement component 5 deficiency.	Peripheral blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C5 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting is necessary.", "Complete a genetic counselling session prior to collection.", "Bring any prior immunological or complement reports.", "Do not alter prophylactic antibiotics unless directed by your physician."] Indications ["Personal or family history of invasive meningococcal disease", "Recurrent neisserial infections", "Symptoms suggestive of a terminal complement defect"] Measurement technique Confirm with laboratory Codes LOINC: 81405-5 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C5 gene associated with complement component 5 deficiency.
TEST-497 CA 27.29 and CA 15.3 Breast Cancer Markers Panel Test This test measures the levels of two specific tumor markers, CA 27.29 and CA 15.3, in the blood to help monitor patients with known breast cancer.	Serum	2–3 weeks from receipt	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA 27.29 (Mucin-1 glycoprotein antigen)", "CA 15.3 (Mucin-1 glycoprotein antigen)"] Parameters [{"name": "CA 27.29", "reference_range": null}, {"name": "CA 15.3", "reference_range": null}] Preparation ["No fasting required", "Provide a complete list of current medications and supplements", "Avoid strenuous exercise for 12 hours before collection", "Hydrate normally"] Indications ["Monitoring for recurrence in patients with histologically confirmed breast cancer", "Evaluating therapeutic efficacy in breast cancer patients", "Longitudinal surveillance protocols"] Measurement technique Confirm with laboratory Codes LOINC: 12020-8 ICD-10: C50.9 Clinical summary This test measures the levels of two specific tumor markers, CA 27.29 and CA 15.3, in the blood to help monitor patients with known breast cancer.
TEST-4388 CACNA1A Gene Episodic Ataxia Type 2 Genetic Test This genetic test evaluates the CACNA1A gene for pathogenic variants associated with episodic ataxia type 2.	Whole Blood (EDTA tube), Extracted DNA, One‑drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1A gene", "Copy number variants in the CACNA1A gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of episodic ataxia type 2", "Family history of episodic ataxia type 2", "Differential diagnosis of ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 99803-9 ICD-10: G11.9 Clinical summary This genetic test evaluates the CACNA1A gene for pathogenic variants associated with episodic ataxia type 2.
TEST-3566 CACNA1D Gene Analysis Test This test analyzes the CACNA1D gene for mutations associated with primary aldosteronism and neurological disorders.	Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "SNVs, indels, copy number variants (CNVs)"] Parameters [] Preparation ["No fasting or special preparation is needed", "Pre-test genetic counselling session is mandatory"] Indications ["Suspected primary aldosteronism", "Early-onset seizure disorders", "Progressive neurological abnormalities of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E26.0, G40.9 Clinical summary This test analyzes the CACNA1D gene for mutations associated with primary aldosteronism and neurological disorders.
TEST-4407 CACNA1H Genetic Susceptibility Testing for Childhood Absence Epilepsy Type 6 Test This test identifies pathogenic variants in the CACNA1H gene associated with childhood absence epilepsy type 6.	Peripheral Whole Blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1H gene"] Parameters [] Preparation ["No fasting required", "Maintain normal diet and medication schedule"] Indications ["Suspected childhood absence epilepsy type 6", "Family history of childhood absence epilepsy type 6"] Measurement technique Confirm with laboratory Codes LOINC: 95857-7 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the CACNA1H gene associated with childhood absence epilepsy type 6.
TEST-4851 CACNA1S Gene Malignant Hyperthermia Type 5 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene associated with susceptibility to malignant hyperthermia type 5 (MHS5).	Whole Blood (EDTA) or FTA Card Drop	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1S gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["No fasting or special preparation required", "Mandatory pre-test genetic counselling session required", "Complete clinical history and three-generation pedigree chart required", "Signed informed consent form required"] Indications ["Pre-anesthetic risk stratification", "Family cascade screening", "Evaluation of unexplained perioperative complications", "Assessment of muscle channelopathies"] Measurement technique Confirm with laboratory Codes LOINC: 94869-5 ICD-10: Z15.09 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene associated with susceptibility to malignant hyperthermia type 5 (MHS5).
TEST-5823 CACNA1S Gene: Thyrotoxic Periodic Paralysis Type 1 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene associated with thyrotoxic periodic paralysis type 1.	Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CACNA1S gene coding exons and splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected thyrotoxic periodic paralysis type 1", "Family history of periodic paralysis", "Differential diagnosis of episodic weakness"] Measurement technique Confirm with laboratory Codes LOINC: 48019-1 ICD-10: G72.3 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene associated with thyrotoxic periodic paralysis type 1.
TEST-496 Cadmium 24-Hour Urine Test This test measures the total amount of cadmium excreted in urine over a 24-hour period to assess chronic exposure and potential kidney damage.	24-Hour Urine	24 hours (sample collected by 6 PM, report by next day)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Total cadmium excretion", "Kidney function related to cadmium exposure"] Parameters [{"name": "Cadmium", "reference_range": null}] Preparation ["Avoid seafood for 3 days prior to collection", "Wait 96 hours after Gadolinium or Iodine-based contrast media administration", "Use only the provided sterile container and gloves"] Indications ["Diagnosing chronic cadmium toxicity", "Monitoring occupational exposure", "Evaluating kidney function in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 5620-9 ICD-10: T56.3 Clinical summary This test measures the total amount of cadmium excreted in urine over a 24-hour period to assess chronic exposure and potential kidney damage.
TEST-506 Cadmium Blood Test This diagnostic test evaluates the concentration of toxic cadmium in whole blood.	Whole Blood (peripheral)	Next Day (report by 9 PM)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Toxic cadmium levels", "Heavy metal exposure"] Parameters [{"name": "Cadmium", "reference_range": null}] Preparation ["Strictly avoid seafood (fish, shellfish) for 3 days prior to collection", "Inform phlebotomist if received Gadolinium or Iodine contrast within 96 hours", "No fasting required"] Indications ["Occupational exposure monitoring (battery manufacturing, welding, mining)", "Investigation of heavy metal poisoning", "Evaluation of unexplained kidney or bone issues"] Measurement technique Confirm with laboratory Codes LOINC: 5608-8 ICD-10: T56.891 Clinical summary This diagnostic test evaluates the concentration of toxic cadmium in whole blood.
TEST-500 Cadmium Random Urine Test This diagnostic test evaluates the concentration of cadmium in a random urine sample to assess recent or chronic exposure.	Random Urine (spot urine)	Next Day (report by 6 pm)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cadmium concentration in urine", "Recent or chronic cadmium exposure"] Parameters [{"name": "Cadmium", "reference_range": "< 0.1 µg/L"}] Preparation ["Abstain from seafood for 3 days prior to collection.", "Do not discontinue prescribed medications without consulting your doctor."] Indications ["Occupational exposure monitoring (battery manufacturing, electroplating, pigment industries)", "Nephrotoxicity evaluation", "Environmental risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 5586-2 ICD-10: Z77.078 Clinical summary This diagnostic test evaluates the concentration of cadmium in a random urine sample to assess recent or chronic exposure.
TEST-510 Calcitonin Test This diagnostic test evaluates the level of calcitonin hormone in the serum, primarily used as a marker for medullary thyroid carcinoma.	Serum	Same day (sample collected Mon/Thu by 11 AM)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Calcitonin hormone levels", "Parafollicular C-cell activity"] Parameters [{"name": "Calcitonin", "reference_range": null}] Preparation ["Fast for 8–12 hours before the blood draw.", "Inform the clinician about all medications, including proton-pump inhibitors and calcium-channel blockers."] Indications ["Diagnosis of medullary thyroid carcinoma (MTC)", "Screening for multiple endocrine neoplasia type 2 (MEN2)", "Monitoring MTC recurrence"] Measurement technique Confirm with laboratory Codes LOINC: 10489-9 ICD-10: C73 Clinical summary This diagnostic test evaluates the level of calcitonin hormone in the serum, primarily used as a marker for medullary thyroid carcinoma.
TEST-3973 CAMTA1 Gene Genetic Test for Non-Progressive Cerebellar Ataxia with Intellectual Disability This test evaluates the CAMTA1 gene for pathogenic variants associated with non-progressive cerebellar ataxia and intellectual disability.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAMTA1 gene variants", "Pathogenic mutations", "Likely pathogenic mutations", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [{"name": "CAMTA1 Gene Analysis", "reference_range": "No pathogenic or likely pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of non-progressive cerebellar ataxia with intellectual disability", "Genetic counseling for affected families", "Carrier screening in families with known CAMTA1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 94222-6 ICD-10: G11.2, F70 Clinical summary This test evaluates the CAMTA1 gene for pathogenic variants associated with non-progressive cerebellar ataxia and intellectual disability.
TEST-519 Canavan Disease (Aspartoacylase Deficiency) Screening Test, Urine This diagnostic test evaluates for Canavan disease by quantifying N-acetylaspartic acid (NAA) levels in urine.	Urine (random void)	5 working days	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["N-acetylaspartic acid (NAA) concentration in urine", "Aspartoacylase enzyme deficiency (indirectly)"] Parameters [{"name": "N-acetylaspartic acid (NAA)", "reference_range": null}] Preparation ["No specific fasting required", "Ensure adequate hydration", "Do not discontinue prescribed medications without consulting a doctor"] Indications ["Infants with symptoms suggestive of Canavan disease", "Follow-up for borderline newborn screening results", "Family history of Canavan disease"] Measurement technique Confirm with laboratory Codes LOINC: 22690-4 ICD-10: E75.29, Z13.228, R82.998 Clinical summary This diagnostic test evaluates for Canavan disease by quantifying N-acetylaspartic acid (NAA) levels in urine.
TEST-540 Cannabinoids (Delta-9-THC Metabolites) / Marijuana Confirmation Urine Test This diagnostic test evaluates the presence and quantity of Delta-9-THC metabolites (THC-COOH) in urine.	Urine	5 business days	7,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Delta-9-THC Metabolites (THC-COOH)", "Quantitative THC-COOH levels"] Parameters [{"name": "THC-COOH", "reference_range": "Negative"}] Preparation ["No specific fasting required.", "Avoid preservatives in the urine sample."] Indications ["Legal requirements", "Employment screening", "Treatment monitoring", "Suspicion of drug use"] Measurement technique Confirm with laboratory Codes LOINC: 16232-3 ICD-10: Z04.89 Clinical summary This diagnostic test evaluates the presence and quantity of Delta-9-THC metabolites (THC-COOH) in urine.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories